Home - Products - Others - Other Targets - Acetyl-Hirudin (55-65) (sulfated)

Acetyl-Hirudin (55-65) (sulfated)

CAS No. 125441-01-2

Acetyl-Hirudin (55-65) (sulfated)( ——— )

Catalog No. M39960 CAS No. 125441-01-2

Acetyl-Hirudin (55-65) (sulfated) is a Acetyl-fragment of Hirudin. Hirudin is a thrombin inhibitor with blood anticoagulant property.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Acetyl-Hirudin (55-65) (sulfated)
  • Note
    Research use only, not for human use.
  • Brief Description
    Acetyl-Hirudin (55-65) (sulfated) is a Acetyl-fragment of Hirudin. Hirudin is a thrombin inhibitor with blood anticoagulant property.
  • Description
    Acetyl-Hirudin (55-65) (sulfated) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    125441-01-2
  • Formula Weight
    1533.57
  • Molecular Formula
    C66H92N12O28S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Birnbaum S, et al. Peptide screening. Current Opinion in Biotechnology, 1992, 3(1): 49-54.
molnova catalog
related products
  • 3X FLAG peptide TFA

    The 3X FLAG Peptide is a synthetic peptide of 23 amino acid residue. The Asp-Tyr-Lys-Xaa-Xaa-Asp motif is repeated three times in the peptide.

  • Cyanidin3-glucopyran...

    Cyanidin3-glucopyranosyl-(1→6)-[3-xylopyranosyl-(1→2)]-galactopyranoside

  • Laquinimod

    Laquinimod (ABR-215062) is an immunoregulator derived from Linomide, has been shown to completely inhibit the development of murine acute experimental autoimmune encephalomyelitis (EAE).